About Metroplex Pulmonary and Sleep Center
Clinical Trials at Metroplex Pulmonary and Sleep Center
During the past decade, Metroplex Pulmonary and Sleep Center conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 11 clinical trials were completed, i.e. on
average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 7 clinical trials were completed. i.e. 70%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Metroplex Pulmonary and Sleep Center" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Bellus Health Inc" with 2 trials
sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Verona Pharma plc"
with 2 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Metroplex Pulmonary and Sleep Center"
#1 collaborator was "Iqvia Pty Ltd" with 2 trials as a collaborator and "LGC Limited" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Metroplex Pulmonary and Sleep Center
According to Clinical.Site data, the most researched conditions in "Metroplex Pulmonary and Sleep Center" are
"Idiopathic Pulmonary Fibrosis" (7 trials), "Asthma" (5 trials), "Chronic Obstructive Pulmonary Disease" (2 trials), "Refractory Chronic Cough" (2 trials) and "Bronchiectasis" (1 trials). Many other conditions were trialed in "Metroplex Pulmonary and Sleep Center" in a lesser frequency.
Clinical Trials Intervention Types at Metroplex Pulmonary and Sleep Center
Most popular intervention types in "Metroplex Pulmonary and Sleep Center" are "Drug" (22 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "BLU-5937" (2 trials), "Lebrikizumab" (2 trials), "Nintedanib" (2 trials) and "PRM-151 (Zinpentraxin Alfa)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Metroplex Pulmonary and Sleep Center
The vast majority of trials in "Metroplex Pulmonary and Sleep Center" are
22 trials for "All" genders.
Clinical Trials Status at Metroplex Pulmonary and Sleep Center
Currently, there are NaN active trials in "Metroplex Pulmonary and Sleep Center".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 15 completed trials in Metroplex Pulmonary and Sleep Center,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Metroplex Pulmonary and Sleep Center, 0 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".